New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 11, 2013
06:40 EDTNSTGNanoString upgraded to Outperform from Neutral at RW Baird
Baird upgraded NanoString following the announcement that several leading U.S. clinical labs and cancer centers will offer Prosigna breast cancer diagnostic tests in Q1 2014. The firm believes the initial customer wave represents over 50% of potential volumes and raised its price target to $18 from $12.
News For NSTG From The Last 14 Days
Check below for free stories on NSTG the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for NSTG

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use